The National Institute of Neurological Disorders and Stroke (NINDS) is offering this grant to support critical research in Parkinson’s Disease (PD). This funding opportunity aims to discover biomarkers that will enhance the efficiency and outcomes of Phase II clinical trials for PD. Additionally, it seeks to support the collection of vital clinical data and new biological specimens for ongoing biomarker exploratory efforts under the NINDS Parkinson’s Disease Biomarkers Program (PDBP). Applications may encompass both goals, utilizing existing or new cohorts. A key requirement is broad sharing of all collected data and biological specimens with researchers across academia, industry, and government. This ensures the development of valuable research resources, accelerating PD research. Applicants must provide strong statistical justification and scientific rationale for proposed subjects and samples, and ensure proper consent for data distribution.
Opportunity ID: 154073
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-NS-12-011 |
| Funding Opportunity Title: | Studies in Parkinson’s Disease Biomarkers Discovery (U01) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.853 — Extramural Research Programs in the Neurosciences and Neurological Disorders |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 16, 2012 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | May 23, 2012 |
| Current Closing Date for Applications: | May 23, 2012 |
| Archive Date: | Jun 23, 2012 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments County governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Private institutions of higher education Small businesses Independent school districts City or township governments Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities Others (see text field entitled “Additional Information on Eligibility” for clarification) Special district governments Native American tribal organizations (other than Federally recognized tribal governments) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this funding opportunity announcement (FOA) is to 1) support hypothesis driven clinical research to discover biomarkers that will improve the efficiency and outcome of Phase II clinical trials for Parkinsons Disease (PD) and 2) support the collection of clinical data and new biological specimens that will be used for biomarker exploratory efforts under the NINDS Parkinsons Disease Biomarkers Program (PDBP). Applications may include both of these goals if justified. Studies using either existing or new cohorts may be appropriate. For all applications, applicants must describe statistical justification for the number of subjects/samples proposed and a clear scientific rationale for the range and types of subjects/samples to be collected. Broad sharing of data and biological specimens with academic, industry and government researchers is a critical feature of the PDBP generally and of this FOA specifically, in order to provide valuable research resources for the scientific community to advance Parkinsons Disease research in an efficient and effective manner (consistent with applicable laws, regulations, and policies); therefore, all subjects in any proposed study must be properly consented to allow appropriate sample and data distribution to researchers in academics and industry. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-12-011.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.853 | ADOBE-FORMS-B2 | ADOBE-FORMS-B2 | PKG00106631 | Apr 23, 2012 | May 23, 2012 | View |
Package 1
Mandatory forms
154073 RR_SF424_1_2-1.2.pdf
154073 PerformanceSite_1_4-1.4.pdf
154073 RR_OtherProjectInfo_1_3-1.3.pdf
154073 RR_KeyPersonExpanded_1_2-1.2.pdf
154073 PHS398_CoverPageSupplement_1_4-1.4.pdf
154073 PHS398_ResearchPlan_1_3-1.3.pdf
154073 PHS398_Checklist_1_3-1.3.pdf
Optional forms
154073 RR_SubawardBudget30-1.2.pdf
154073 PHS398_ModularBudget_1_2-1.2.pdf
154073 RR_Budget-1.1.pdf
154073 PHS_CoverLetter_1_2-1.2.pdf